生物
肠道菌群
失调
基因组
蛋白质细菌
发病机制
人口
遗传学
内科学
免疫学
基因
医学
16S核糖体RNA
环境卫生
作者
Qi Cheng,Chao Fan,Fengyun Liu,Yuan Li,Haiwen Hou,Yan Ma,Yueqing Tan,Yuxian Li,Yue Hai,Tianyi Wu,Liangzhi Zhang,Yanming Zhang
出处
期刊:Genomics
[Elsevier]
日期:2022-11-01
卷期号:114 (6): 110483-110483
标识
DOI:10.1016/j.ygeno.2022.110483
摘要
The gut microbiota plays a crucial role in coronary heart disease (CHD). However, only a few studies focusing on the relationship between gut microbiota and CHD in ethnic populations are available. Here, we employed shotgun sequencing of the gut metagenome to analyze the taxonomic composition and functional annotation of the gut microbiota of 14 CHD patients, 13 patients with non-stenosis coronary heart disease (NCHD), and 18 healthy controls (HT) in Tibetan subjects. We found that the α-diversity of the gut microbiota was not significantly different among the three groups., whereas β-diversity was significantly altered in the CHD group compared with HT. Based on the receiver operating characteristic curve (ROC) analysis, the relative abundance of Proteobacteria species effectively distinguished patients with CHD from the control group. Most of the enriched species belonged to Proteobacteria. The pathways that contributed the most to the differences between groups were amino acid metabolism-related pathways, especially lysine biosynthesis. The enzymes of the lysine biosynthesis pathway, including K01714 and K00821, were significantly decreased in the CHD group. Our findings increase the understanding of the association between CHD pathogenesis and gut microbiota in the Tibetan population, thus paving the way for the development of improved diagnostic methods and treatments for Tibetan patients with CHD.
科研通智能强力驱动
Strongly Powered by AbleSci AI